Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 medications to discover one treatment which may work.

Bouaynaya’s appointment represents a significant investment in leveraging AI to drive Rowan University's strategic growth. As ...

Two final-year Medicine students design consultation tools thanks to a grant from the Cris Foundation against Cancer. After a cancer diagnosis, it is inevitable to type the type on the internet and ...

Dr. Koushik Kasanagottu, a public health expert and assistant clinical professor in the Department of Internal Medicine at ...

The global incidence of cancer reached 20 million in 2022 and is projected to rise to 33·1 million by 2050.1 Amid the growing ...

Highlights the role of artificial intelligence in early rare disease detection, diagnosis, and treatment, with the ...

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease.

Two things can be true: Holding back Chinese technology like DeepSeek and TikTok could be good for America, but it also hurts America. The developer of the chatbot that shocked U.S. incumbents had ...

Hospitals across the country are using artificial intelligence. See how guardrails vary from location to location.

A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...